Evidence map›Paper›PMID 21944317›Full record

ArticleGender medicine2012

Optical technologies and molecular imaging for cervical neoplasia: a program project update.

Timon P H Buys, Scott B Cantor, Martial Guillaud, Karen Adler-Storthz, Dennis D Cox, Clement Okolo, Oyedunni Arulogon, Oladimeji Oladepo, Karen Basen-Engquist, Eileen Shinn and 17 more

Abstract read
In one paragraph

Article in Gender medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Timon P H BuysImaging Unit, Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada. tbuys@bccrc.ca
Scott B Cantor
Martial Guillaud
Karen Adler-Storthz
Dennis D Cox
Clement Okolo
Oyedunni Arulogon
Oladimeji Oladepo
Karen Basen-Engquist
Eileen Shinn
José-Miguel Yamal
J Robert Beck
Michael E Scheurer
Dirk van Niekerk
Anais Malpica
Jasenka Matisic
Gregg Staerkel
Edward Neely Atkinson
Luc Bidaut
Pierre Lane
J Lou Benedet
Dianne Miller
Tom Ehlen
Roderick Price
Isaac F Adewole
Calum MacAulay
Michele Follen

Funding

Technical FeasibilityP01CA082710 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GUILLAUD, MARTIAL · 1999 to 2014
$28.7M
NCI NIH HHS P01 CA082710
6 · The paper itself

Abstract

There is an urgent global need for effective and affordable approaches to cervical cancer screening and diagnosis. In developing nations, cervical malignancies remain the leading cause of cancer-related deaths in women. This reality may be difficult to accept given that these deaths are largely preventable; where cervical screening programs have been implemented, cervical cancer-related deaths have decreased dramatically. In developed countries, the challenges of cervical disease stem from high costs and overtreatment. The National Cancer Institute-funded Program Project is evaluating the applicability of optical technologies in cervical cancer. The mandate of the project is to create tools for disease detection and diagnosis that are inexpensive, require minimal expertise, are more accurate than existing modalities, and can be feasibly implemented in a variety of clinical settings. This article presents the status and long-term goals of the project.

Indexed as

ColposcopyEquipment DesignFemaleHumansMass ScreeningMicroscopy, InterferenceSpectrometry, FluorescenceSpectrum AnalysisUterine Cervical Neoplasms

Identifiers

PMID21944317
PMCPMC3289763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.